Oxford vaccine is protective against the U.K. variant, preprint says
The results were posted in a preprint server. Preprints are yet to be peer-reviewed and published in scientific journals. No
Read More
SARS-CoV-2
Causality assessment of COVID-19 vaccine deaths will be made public, says National AEFI Committee advisor
On January 31, when 11 deaths of health-care and frontline workers were reported from across the country following administration of
Read More
Updated efficacy results underline the benefits of delaying second dose of Oxford vaccine
The data in the preprint show that vaccine efficacy was high when the interval between the two doses was two
Read More
Reneging on the ‘no-profit pledge’ to supply Oxford vaccine
On the say day the release was sent out announcing the partnership with AstraZeneca, Oxford University also tweeted saying that the
Read More
With more vaccines than vaccinations, India exports Covishield before expiry date
It is true that while the U.S. took 10 days to breach the one-million mark and the U.K. took 18
Read More
Study finds Covaxin effective against the UK variant
The sera from people vaccinated with Covaxin were tested against the same strain used for making the vaccine, another strain
Read More
Glitches in CoWIN also responsible for low COVID-19 vaccine uptake
On January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking
Read More
Indian scientists divided over restricted use approval for Covaxin
In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the
Read More
Vaccine dilemma: To take or not to take Covaxin
True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing
Read More
Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial
The phase-3 clinical trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, by a private hospital in the Bhopal-based Peoples College of
Read More
New challenges in conducting COVID-19 vaccine trials in India
The Ahmedabad-based Zydus Cadilla only recently got the regulatory permission to carry out phase-3 trial and has to begin the
Read More
I would not take Covaxin without efficacy data: Gagandeep Kang
Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use.
Read More
Can the lockdown in England control new variant spread?
As on December 4, U.K has reported 2.7 million cases and over 75,500 deaths, the second highest death toll in
Read More